CACNA1D Gene Sinoatrial Node Dysfunction and Deafness Genetic Test
Test Name: CACNA1D Gene Sinoatrial Node Dysfunction and Deafness Genetic Test
Components: Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Ear Nose Throat Disorders
Doctor: ENT Doctor
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for PTPN23 Gene Ciliogenesis related disorder NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PTPN23 Gene Ciliogenesis related disorder NGS Genetic DNA Test gene PTPN41
Test Details
The CACNA1D gene is associated with both sinoatrial node dysfunction and deafness. Sinoatrial node dysfunction refers to abnormalities in the heart’s natural pacemaker, which can lead to irregular heartbeats and other cardiac issues. Deafness, on the other hand, refers to a partial or complete loss of hearing.
NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously to identify any genetic variations or mutations that may be associated with a particular condition. In the case of the CACNA1D gene, NGS genetic testing can be used to identify any mutations or variations in this gene that may be causing sinoatrial node dysfunction and/or deafness.
By analyzing the CACNA1D gene through NGS genetic testing, healthcare professionals can determine if there are any specific genetic variations or mutations that may be contributing to the development of these conditions. This information can help in diagnosing and managing the conditions, as well as providing genetic counseling and guidance for affected individuals and their families.
Test Name | CACNA1D Gene Sinoatrial node dysfunction and deafness Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Ear Nose Throat Disorders |
Doctor | ENT Doctor |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for PTPN23 Gene Ciliogenesis related disorder NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PTPN23 Gene Ciliogenesis related disorder NGS Genetic DNA Test gene PTPN41 |
Test Details |
The CACNA1D gene is associated with both sinoatrial node dysfunction and deafness. Sinoatrial node dysfunction refers to abnormalities in the heart’s natural pacemaker, which can lead to irregular heartbeats and other cardiac issues. Deafness, on the other hand, refers to a partial or complete loss of hearing. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously to identify any genetic variations or mutations that may be associated with a particular condition. In the case of the CACNA1D gene, NGS genetic testing can be used to identify any mutations or variations in this gene that may be causing sinoatrial node dysfunction and/or deafness. By analyzing the CACNA1D gene through NGS genetic testing, healthcare professionals can determine if there are any specific genetic variations or mutations that may be contributing to the development of these conditions. This information can help in diagnosing and managing the conditions, as well as providing genetic counseling and guidance for affected individuals and their families. |